REBECCA F DAVIS

Physician Assistants & Advanced Practice Nursing Providers|Advanced Practice Midwife PORT ALLEN, LA NPI 1477585230

General Payments — all program years on this page

$907.27

  • Category: General Payments
  • Program years: PY2021–2024
  • Record count: 50
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $364.15 across 20 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $364.1520

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2021 $66.634
2022 $246.6113
2023 $229.8813
2024 $364.1520

Records — PY2024 (20)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1106995630 ABBVIE INC. $13.54 06/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1114455061 Exact Sciences Corporation $14.40 05/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116760572 Renalytix AI, Inc. $18.05 01/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116760574 Renalytix AI, Inc. $22.33 03/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116760576 Renalytix AI, Inc. $16.10 04/01/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116760578 Renalytix AI, Inc. $19.24 04/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116760580 Renalytix AI, Inc. $20.30 05/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116760582 Renalytix AI, Inc. $21.58 06/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1119055812 Otsuka America Pharmaceutical, Inc. $14.04 04/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1125084371 Abbott Laboratories $19.18 04/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1125084373 Abbott Laboratories $23.81 07/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1125084375 Abbott Laboratories $18.54 07/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1133938686 Vanda Pharmaceuticals Inc. $27.43 12/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139549311 Astellas Pharma US Inc $15.51 11/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1143422792 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $16.93 03/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1143422796 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $16.93 05/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1143422799 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $18.03 06/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1143422803 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $15.96 06/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1143422807 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $17.84 11/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1146281864 IRONSHORE PHARMACEUTICALS INC. $14.41 05/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.